214 filings
Page 8 of 11
8-K
4jdh4 g3ej
7 Jan 19
Regulation FD Disclosure
7:00am
8-K
0hxx3g
20 Dec 18
Departure of Directors or Certain Officers
4:02pm
8-K
0d7wzd
8 Nov 18
Kala Pharmaceuticals Reports Third Quarter 2018 Financial Results
4:05pm
8-K
6tz d874ita3bjwf
1 Nov 18
Departure of Directors or Certain Officers
4:01pm
8-K
1a6u18v
16 Oct 18
Other Events
9:00am
8-K
lcvsfkglg
11 Oct 18
Kala Pharmaceuticals Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
4:11pm
CT ORDER
wrmw22lqwu4xq918
9 Oct 18
Confidential treatment order
12:00am
8-K
6haer4tyrv63
5 Oct 18
Kala Pharmaceuticals Announces Pricing of Public Offering of 7,500,000 Shares of Common Stock
6:01am
424B2
qn1n 4wtg
3 Oct 18
Prospectus for primary offering
5:26pm
424B2
edmw1k4fa6i86ls
2 Oct 18
Prospectus for primary offering
5:26pm
8-K
7jbpnoey52 mo8d2oj
2 Oct 18
Other Events
4:40pm
8-K
cguhrs046 kssxg
2 Oct 18
Kala Pharmaceuticals Announces Financing from Athyrium Capital Management Totaling $110 Million
4:38pm
8-K
6i7b7uuk jssz1hguwh
5 Sep 18
Regulation FD Disclosure
12:00am
EFFECT
hvyvc1
27 Aug 18
Notice of effectiveness
12:00am
CORRESP
gh5c9nk9slvgwnwsx
23 Aug 18
Correspondence with SEC
12:00am
8-K
irg0 0j8g
23 Aug 18
Kala Pharmaceuticals Announces FDA Approval of INVELTYSTMÂ for the Treatment of Post-Operative Inflammation and Pain Following Ocular Surgery
12:00am
CT ORDER
pcksq
22 Aug 18
Confidential treatment order
12:00am
CORRESP
14df9aog
20 Aug 18
Correspondence with SEC
12:00am
S-3/A
ghtpsm2xho6pvd53x75a
20 Aug 18
Shelf registration (amended)
12:00am